Bacil Pharma Q3 Results
- BSE: 524516
- NSE: -
- ISIN: INE711D01018
- Sector: Biotechnology & Drugs
BSE
45.17
0.87 (1.96%)
0.87 (1.96%)Volume7.30 K
Updated: Tue 26 Nov, 2024 | 15:15:00
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Bacil Pharma Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 23 | Sep 23 | QoQ Comp |
|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | -% |
| Selling/ General/ Admin Expenses Total | 0.03 | 0.02 | -% |
| Depreciation/ Amortization | 0.00 | 0.00 | -% |
| Other Operating Expenses Total | 0.02 | 0.02 | -% |
| Total Operating Expense | 0.06 | 0.04 | -% |
| Operating Income | -0.06 | -0.04 | -% |
| Net Income Before Taxes | -0.02 | -0.01 | -% |
| Net Income | -0.02 | -0.01 | -% |
| Diluted Normalized EPS | -0.04 | -0.02 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment status out. GMP, how to check status online
2 min read06:38 AM IST - Markets
02Enviro Infra Engineers IPO day 3: GMP rises after strong subscription status. Apply or not?
3 min read03:38 PM IST - Markets
03Stock market today: Trade setup for Nifty 50, gold to Russia-Ukraine war; 5 stocks to buy or sell on Tuesday — Nov 26
5 min read06:44 AM IST